Experimental Section
Materials and reagents. The nucleic acid release probe (sequence: 5'-CCCCTATCACGATTAGCATTAAAAAAAAAA-3') was synthesized by Integrated DNA Technologies (Coralville, IA), while both the capture probe (sequence: 5'-TCACGATTAGCCCCCCCCCC-(3'-Biotin)-3') and the target lung cancer biomarker microRNA (sequence: 5'-UUAAUGCUAAUCGUGAUAGGGG-3') were purchased from the Midland Certified Reagent Company (Midland, TX). All the nucleic acid solutions were prepared with DNase, RNase free water (Sigma-Aldrich) with their stock solutions at 1 mM each, and were kept at -20° immediately before and after use. Streptavidin modified magnetic beads (4mg/mL) ， rabbit whole blood (containing alsevers solution), and fetal bovine serum were obtained from New England BioLabs, Inc. (Ipswich, MA), HemoStat Laboratories (Dixon, CA), and Fisher Scientific (Suwanee, GA), respectively. Rabbit whole blood was kept at 4° C, while serum is stored at -20° C before and after use. Unless stated otherwise, all the other chemicals and reagents used in this study were purchased from Sigma-Aldrich (St. Louis, MO), and prepared with HPLC-grade water (ChromeAR, Mallinchkrodt Baker).
Planar bilayer experiments.
Lipid bilayer was formed using 1,2-diphytanoylphosphatidylcholine (DPhPC, Avanti Polar Lipids, Alabaster, AL) according to the Montal-Mueller method S1 . The insertion of α-hemolysin protein ion channel (0.01-0.1 ng/mL) into the bilayer membrane was achieved using a procedure as described in our previous reports S2 . A pair of Ag/AgCl electrodes was employed to connect the cis (grounded) and trans compartments of the nanopore sensing chamber. Each chamber compartment contained an electrolyte buffer solution of 1 M KCl and 10 mM Tris-HCl (pH 8.0). The transmenbrane ionic current of the single α-hemolysin nanopore channel was recorded using a patch-clamp amplifier (Axopatch 200B, Molecular Devices, Sunnyvale, CA) under an applied potential bias of +160 mV, unless stated otherwise. The current recording was filtered with a four-pore low-pass Bessel filter at 5 kHz, and digitized with a 1440A converter (Molecular Device) at a sampling frequency of 50 kHz. All the signatures of current modulations (events) were analyzed using Clampfit 10.5 software (Molecular Device).
Blood and serum sample analysis. The procedure for nanopore analysis of blood and serum samples was consisted of three main steps. The first step involved the coupling of biotin-modified ssDNA (i.e., capture probe) to the streptavidin-modified magnetic beads. Briefly, 250 L of 4 mg/mL streptavidin-modified magnetic beads was washed with 100 L washing/binding buffer (0.5 M NaCl, 20 mM Tris-HCl, 1 mM EDTA, pH 7.5). After applying a magnet to the beads and removing the supernatant, 250 nM biotin-modified ssDNA was added to the magnetic beads to form capture probe-beads complexes. The coupling reaction was held at room temperature for 10 min with occasional agitation. Then, the magnet was applied to remove the supernatant, followed by washing the capture probe-beads complex three times with the washing/binding buffer. Next, 20 L of rabbit blood or fetal bovine serum spiked with a certain concentration of the target microRNA (ranging from 50 to 200 nM) and 400 L of the washing/binding buffer were added to the prepared capture probe-beads complex. After 10-min incubation with occasional agitation, magnet was applied to remove the supernatant. Then, the produced capture probe-microRNA-beads complex was washed with 100 L washing/binding buffer, followed by applying the magnet to remove the supernatant. In the third step, 250 nM of replacement probe was added to the capture probe-microRNA-beads complex. After 15 min incubation (with stirring) and applying the magnet to the beads, the supernatant (containing release probe-microRNA duplex) was collected for nanopore analysis. It should be noted that, to improve the efficiency of hybridization, nucleic acid molecules were heated to 95 °C and then cooled in an ice bath for 3 minutes before the hybridization reaction.
Calculation of MicroRNA Recovery
The percent microRNA recovery from the blood sample was calculated by dividing the 
Determination of the Efficiency of the Capture Probe
The percent microRNA loss during the process of utilizing the capture probe to collect the Dashed lines represent the levels of zero current. The characteristic release probe-microRNA duplex events were highlighted (black dot-marked). The microRNA samples (without/with serum) were analyzed according to the displacement chemistry-based nucleic acid detection principle and using the procedure as described in the experimental section. The concentrations of capture probe, microRNA, and release probe used in Fig. S8a were 250 nM, 200 nM, and 250 nM, respectively, while those in Fig. 8b were 500 nM, 200 nM, and 500 nM, respectively. 
